Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | RNAZ TransCode Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.68 +3.1% | $16.31 +6.3% |
| StockIQ Score | 41D Weak Risk: High | 42D Weak Risk: Medium |
| Technical | 27F | 36F |
| Fundamental | 46D+ | 35F |
| Growth | 46D+ | 50C- |
| Fair Value | 50C- | 38F |
| News | 44D | 50C- |
| Quality | — | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
RNAZ shows stronger fundamental and growth scores (both 46) compared to AAPG’s 35 and 50, respectively. AAPG leads slightly in valuation (50 vs. RNAZ’s 50, but RNAZ’s technical score (27) lags behind AAPG’s 36. Both carry a "WEAK" rating, but RNAZ’s investor score (41) is marginally lower than AAPG’s 42.
